E-nose Sniffs Out Rare Lung Disease

Add bookmark
A new technology referred to as an artificial nose has the ability to detect a rare progressive lung disease from a patient’s breath. The enose, produced by Université Paris-Saclay in partnership with the Technion Israel Institute of Technology, is tuned to detect Pulmonary Arterial Hypertension (PAH)- a form of high blood pressure. The disease is known to change the make-up of an individual’s breath.Those suffering from PAH tend to be given a five year life expectancy from diagnosis. The c...

Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended